U.S. Marine and Shipping Stock News

Why Archer-Daniels-Midland (ADM) Is Back On Investors’ Radar Archer-Daniels-Midland (ADM) is drawing fresh attention after a period of mixed short term performance, but with stronger recent momentum prompting investors to reassess the agricultural processor’s role in a diversified equity portfolio. See our latest analysis for Archer-Daniels-Midland. At a share price of US$65.43, ADM has given investors a 14.83% 90 day share price return and a 49.25% total shareholder return over the past...

Circle Internet Group (CRCL) is back in focus after agreeing to supply native USDC settlement infrastructure to prediction market Polymarket, while Ark Invest and Wall Street analysts increase attention during a period of sharp crypto volatility. See our latest analysis for Circle Internet Group. The Polymarket agreement and fresh partnerships on Circle Payments Network have arrived during a sharp reset in sentiment, with a 7 day share price return of 25.64% and a 90 day share price return of...

Hubbell Incorporated recently reported fourth-quarter 2025 results showing higher sales of US$1,492.7 million and net income of US$224.2 million versus a year earlier, and issued 2026 guidance calling for 7% to 9% total sales growth and GAAP diluted EPS of US$17.30 to US$18.00. Alongside these results, the company highlighted expanding margins, ongoing acquisitions such as DMC Power, and the launch of its Aclara360 grid analytics platform, underlining a growing emphasis on higher-value...

Dexcom has introduced new AI-powered upgrades to its Stelo platform, adding expanded Smart Food Logging and a broader nutrition database. The update also includes a redesigned Daily Insights feature that provides more personalized health recommendations for users managing metabolic health. DexCom (NasdaqGS:DXCM) is rolling out these Stelo updates as the stock trades at around $69.89, with a 5.0% return year to date and a 20.9% decline over the past year. The longer term picture has been...

What recent returns suggest about Nasdaq’s current setup Nasdaq (NDAQ) has seen a 3.4% decline over the past day and an 11.7% drop over the past week, extending to a 14.8% slide over the past month and a smaller 2% pullback over the past 3 months. See our latest analysis for Nasdaq. With the share price at $85.51 and a year to date share price return decline of 11.5% alongside a 14.8% 30 day share price return decline, momentum has recently cooled. This contrasts with the 1 year, 3 year and 5...

Insulet has launched its Omnipod 5 Automated Insulin Delivery System in selected Middle Eastern markets. The company also introduced Omnipod Discover, a new data and analytics platform for diabetes management. Both products expand Insulet's global footprint and broaden its connected product ecosystem around Omnipod. Insulet, traded as NasdaqGS:PODD, is adding fresh product news at a time when its share price is $243.15. The stock has seen a 17.4% decline over the past 30 days and a 15.5%...

McDonald’s Board of Directors recently declared a quarterly cash dividend of US$1.86 per share, payable on March 17, 2026, to shareholders of record as of March 3, 2026, while rolling out attention-grabbing promotions such as McNugget Caviar kits and nostalgia-driven Happy Meal toys. These announcements, combined with leadership changes that move experienced international operators into key U.S. and finance roles, highlight how McDonald’s is pairing shareholder returns with brand campaigns...

If you are wondering whether Summit Therapeutics at around US$13.85 is pricing in too much hope or not enough, you are in the right place for a clear look at what the market might be implying about its value. The share price has seen sharp swings, with a 10.1% decline over the past week, a 25.8% decline over the past month, a 20.9% decline year to date, yet a very large gain over three years and an 87.9% gain over five years. These moves have come as Summit Therapeutics continues to attract...

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) received FDA approval for REDEMPLO for familial chylomicronemia syndrome and launched its first commercial product. The company announced a global partnership with Novartis to co develop a preclinical RNAi therapy targeting synucleinopathies. Arrowhead dosed the first subjects in a Phase 1/2a trial of ARO DIMER PA, a first in class dual target RNAi therapeutic for cardiovascular disease. Arrowhead focuses on RNA interference therapies, so this...

Investors wondering whether Nextpower is still fairly priced after a strong run, or if the share price has moved ahead of the underlying value, will find that this article focuses squarely on what the current valuation might be indicating. The stock recently closed at US$114.44, with a 30 day return of 25.1% and a 1 year return of 140.4%. Over the last 7 days, however, the share price has pulled back 5.5%, which may reflect some reassessment of risk or profit taking after a 23.3% year to...

Aon reported fourth-quarter 2025 results showing sales of US$4,300 million and net income of US$1.69 billions, with earnings per share from continuing operations rising materially versus a year earlier. Alongside these figures, Aon outlined an upbeat 2026 outlook and continued to expand its risk, data center and cyber offerings, reinforcing its integrated Aon United model. With this backdrop of strong earnings and enhanced cyber and data center capabilities, we’ll examine how the news shapes...

Innodata (NasdaqGM:INOD) has entered into a partnership with Palantir to provide specialized data engineering and annotation for advanced AI projects. The collaboration focuses on complex, real world use cases, including video annotation and multimodal generative AI workflows for performance analytics in ride event analysis. The agreement positions Innodata as a key data partner for high stakes AI deployments where quality, security and domain specific workflows are central...

If you are wondering whether Lear’s current share price really reflects its underlying value, you are not alone. This article is designed to help you frame that question clearly. Lear’s share price recently closed at US$136.05, with returns of 12.8% over the last 7 days, 10.2% over 30 days, 14.7% year to date, 48.3% over 1 year, 6.6% over 3 years, and a 5.1% decline over 5 years. Recent attention on Lear has been shaped by company updates and sector headlines that have put auto related...

Kratos Defense & Security Solutions (KTOS) has had an active week, landing approximately US$65 million in new military training contracts and advancing its Mighty Hornet IV Attack UAV collaboration with Taiwan’s NCSIST through a successful integrated payload test. See our latest analysis for Kratos Defense & Security Solutions. Despite this steady stream of contract wins and UAV progress, Kratos’ share price has pulled back recently, with a 7 day share price return of 21.18% and a 30 day...

Wayfair stock performance context Wayfair (W) has seen recent share price pressure, with the stock down about 3% over the past day, 18% over the past week, and roughly 19% over the past month. See our latest analysis for Wayfair. Despite the recent 1-month share price return of negative 19.35% and 90-day share price return of negative 17.30% from a last close of US$88.39, Wayfair’s 1-year total shareholder return of 86.59% and 3-year total shareholder return of 52.61% show that longer term...

If you are wondering whether MetLife's current share price reflects its true worth, you are not alone. That is exactly what this valuation focused review aims to unpack. MetLife recently closed at US$75.32, with returns of 3.7% decline over 7 days, 7.2% decline over 30 days, 6.2% decline year to date and 7.3% decline over 1 year, compared with longer term returns of 16.8% over 3 years and 58.5% over 5 years. Recent attention around MetLife has centered on its position as a large, established...

Dole plc (NYSE:DOLE) is voluntarily transitioning to file as a U.S. domestic issuer, while retaining its foreign private issuer status. The company plans to adopt U.S. domestic reporting forms and timelines, which may affect its disclosure practices and index eligibility. U.S. trade policy discussions are ongoing around possible tariff exemptions for certain imported agricultural products, including fruits. These regulatory and trade developments could influence Dole's reporting obligations,...

Corteva (NYSE:CTVA) has reached a comprehensive settlement with Bayer that resolves all "freedom to operate" litigation between the two companies. The agreement is expected to support Corteva's corn licensing activities and open a path into the cotton licensing market. Separately, Corteva is moving ahead with a planned separation of its seed operations into a standalone company. The spin off may include relocating the new seed company headquarters to Iowa, with implications for regional...

Apellis Pharmaceuticals (APLS) has just been added to the S&P 1000, S&P 600, S&P 600 Health Care Sector, and S&P Composite 1500, a shift that can influence trading as index trackers rebalance. See our latest analysis for Apellis Pharmaceuticals. Those index additions come after a mixed share price run, with a 90 day share price return of 17.13% contrasting with a year to date share price decline of 12.76% and a 1 year total shareholder return decline of 25.30%. This suggests recent momentum...

Morningstar’s new private markets indexes Morningstar (MORN) is drawing fresh attention after working with PitchBook to launch indexes that track semiliquid funds investing in private markets, giving investors a new reference point for these vehicles. See our latest analysis for Morningstar. The index launch comes at a time when Morningstar’s share price has been under pressure, with a 7 day share price return of 16.25% and a 30 day share price return of 20.82%. At the same time, the 1 year...

Regal Rexnord (RRX) has wrapped up FY 2025 with fourth quarter revenue of US$1.5 billion and basic EPS of US$0.96, alongside trailing twelve month revenue of US$5.9 billion and EPS of US$4.22 that sit against a 42.5% year over year earnings lift and a 23.4% earnings growth forecast over the next three years. Over recent periods the company has seen quarterly revenue move from US$1,461.1 million in Q4 FY 2024 to US$1,523.2 million in Q4 FY 2025, while basic EPS shifted from US$0.62 to US$0.96,...

Ralph Lauren (NYSE:RL) reported strong third quarter results, with broad-based performance across regions and product categories. The company raised its full-year outlook, reflecting confidence in current business trends. Management highlighted rapid adoption of advanced digital initiatives, including AI-powered shopping tools, and growth in new consumers and digital engagement. For investors watching Ralph Lauren at a share price of $338.66, the recent update comes after a mixed stretch,...

S&T Bancorp (STBA) is back on investor radars after reporting Q4 revenue up 11.5% year on year, edging past analyst forecasts, and pairing that update with a higher quarterly cash dividend. See our latest analysis for S&T Bancorp. At a share price of $44.12, S&T Bancorp has logged a 10.72% 1 month share price return and a 15.35% 3 month share price return. Its 5 year total shareholder return of 88.96% reflects long term compounding and indicates that momentum has been building around its...

Why Pitney Bowes is on investors’ radar now Pitney Bowes (PBI) has drawn fresh attention after recent trading, with the share price around $10.58 and returns over the past 3 months and year standing out against its longer term record. See our latest analysis for Pitney Bowes. Recent trading has added to that focus, with a 90 day share price return of 12.20% and a 1 year total shareholder return of 25.87%. The 3 year total shareholder return of about 19x also stands out against its longer...